Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Breast 2Thoracic 1Plasma cell 1Other 1Myeloid 1Lymphoid 1Gynecologic 1Gastrointestinal 1Dermatologic 1

Conditions

Obesity 1

Interventions

Exercise 4Methods 2Educational Status 2Early Intervention, Educational 2Counseling 2semaglutide 1dexamethasone acetate 1dexamethasone 21-phosphate 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1auricularum 1Ursodeoxycholic Acid 1Urine Specimen Collection 1Ultrasonic Waves 1Topiramate 1Tirzepatide 1Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Robotic Surgical Procedures 1Resistance Training 1Qsymia 1Physical Examination 1Phentermine 1Parturition 1Naltrexone 1Liraglutide 1Interviews as Topic 1Glucagon-Like Peptide-1 Receptor 1Fluorescence Polarization Immunoassay 1Fecal Microbiota Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Exercise Test × Other × Clear all
NCT02774759 2026-03-09

Feasibility of the NEXT Steps Weight Loss Intervention +/- Resistance Training for Endometrial Cancer Survivors: Effect on Lean Mass & Biomarkers

M.D. Anderson Cancer Center

Phase NA Active not recruiting
15 enrolled
Other

Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡